Related references
Note: Only part of the references are listed.Nanomaterial-induced toxicity in pathophysiological models representative of individuals with pre-existing medical conditions
Sreejesh Sreedharan et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS (2023)
Reversing ferroptosis resistance by MOFs through regulation intracellular redox homeostasis
Chengcheng Wang et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2023)
Reactive oxygen species/photothermal therapy dual-triggered biomimetic gold nanocages nanoplatform for combination cancer therapy via ferroptosis and tumor-associated macrophage repolarization mechanism
Yawen Wei et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2022)
L-buthionine sulfoximine encapsulated hollow calcium peroxide as a chloroperoxidase nanocarrier for enhanced enzyme dynamic therapy
Bin Liu et al.
BIOMATERIALS (2022)
Modified peroxamide-based reactive oxygen species (ROS)-responsive doxorubicin prodrugs
Mina Jafari et al.
BIOORGANIC CHEMISTRY (2022)
Cellular reprogramming, chemoresistance, and dietary interventions in breast cancer
Irislene Costa Pereira et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2022)
Cellular and biochemical antileukemic mechanisms of the meroterpenoid Oncocalyxone A
Aline Borba Sbardelotto et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES (2021)
Design and synthesis of isothiocyanate-containing hybrid androgen receptor (AR) antagonist to downregulate AR and induce ferroptosis in GSH-Deficient prostate cancer cells
Zhihui Qin et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives
Zehra Edis et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2021)
Glutathione and its precursors in cancer
Gloria Asantewaa et al.
CURRENT OPINION IN BIOTECHNOLOGY (2021)
pH-Sensitive Polymeric Vesicles for GOx/BSO Delivery and Synergetic Starvation-Ferroptosis Therapy of Tumor
Yang Luo et al.
BIOMACROMOLECULES (2021)
The Duality of Caspases in Cancer, as Told through the Fly
Caitlin Hounsell et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Hollow Gold Nanoparticles Loaded with L-Buthionine-Sulfoximine as a Novel Nanomedicine for In Vitro Cancer Cell Therapy
Min Liu et al.
JOURNAL OF NANOMATERIALS (2021)
Versatile Nanodrugs Containing Glutathione and Heme Oxygenase 1 Inhibitors Enable Suppression of Antioxidant Defense System in a Two-Pronged Manner for Enhanced Photodynamic Therapy
Hao Zhong et al.
ADVANCED HEALTHCARE MATERIALS (2021)
Aminoquinolines as Translational Models for Drug Repurposing: Anticancer Adjuvant Properties and Toxicokinetic-Related Features
Paulo Michel Pinheiro Ferreira et al.
JOURNAL OF ONCOLOGY (2021)
ROS in cancer therapy: the bright side of the moon
Bruno Perillo et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Mouse Tumor-Bearing Models as Preclinical Study Platforms for Oral Squamous Cell Carcinoma
Qiang Li et al.
FRONTIERS IN ONCOLOGY (2020)
Polyurea Dendrimer Folate-Targeted Nanodelivery of l-Buthionine Sulfoximine as a Tool to Tackle Ovarian Cancer Chemoresistance
Adriana Cruz et al.
ANTIOXIDANTS (2020)
Lowering glutathione level by buthionine sulfoximine enhances in vivo photodynamic therapy using chlorin e6-loaded nanoparticles
Jihye Yoo et al.
DYES AND PIGMENTS (2020)
Cell Culture Based in vitro Test Systems for Anticancer Drug Screening
Kristina V. Kitaeva et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
Redox Modulation and Induction of Ferroptosis as a New Therapeutic Strategy in Hepatocellular Carcinoma
Jana Lippmann et al.
TRANSLATIONAL ONCOLOGY (2020)
Glutathione metabolism is essential for self-renewal and chemoresistance of pancreatic cancer stem cells
Petra Jagust et al.
WORLD JOURNAL OF STEM CELLS (2020)
Arsenic Disulfide Combined with L-Buthionine-(S, R)-Sulfoximine Induces Synergistic Antitumor Effects in Two-Dimensional and Three-Dimensional Models of MCF-7 Breast Carcinoma Cells
Yuxue Zhao et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2019)
Overcoming Cancer Cell Drug Resistance by a Folic Acid Targeted Polymeric Conjugate of Buthionine Sulfoximine
Felisa Cilurzo et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2019)
Gamma-Glutamyltransferase 1 Promotes Clear Cell Renal Cell Carcinoma Initiation and Progression
Ankita Bansal et al.
MOLECULAR CANCER RESEARCH (2019)
Synergistic effect of buthionine sulfoximine on the chlorin e6-based photodynamic treatment of cancer cells
Hye Myeong Lee et al.
ARCHIVES OF PHARMACAL RESEARCH (2019)
MRP1 modulators synergize with buthionine sulfoximine to exploit collateral sensitivity and selectively kill MRP1-expressing cancer cells
Christine C. Gana et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Reactive Oxygen Species-Induced Lipid Peroxidation in Apoptosis, Autophagy, and Ferroptosis
Lian-Jiu Su et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Amplification of Tumor Oxidative Stresses with Liposomal Fenton Catalyst and Glutathione Inhibitor for Enhanced Cancer Chemotherapy and Radiotherapy
Ziliang Dong et al.
NANO LETTERS (2019)
Understanding of ROS-Inducing Strategy in Anticancer Therapy
Su Ji Kim et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
The current state of animal models in research: A review
N. Bryce Robinson et al.
INTERNATIONAL JOURNAL OF SURGERY (2019)
Cruciferous Vegetables as Antioxidative, Chemopreventive and Antineoplasic Functional Foods: Preclinical and Clinical Evidences of Sulforaphane Against Prostate Cancers
Paulo M. P. Ferreira et al.
CURRENT PHARMACEUTICAL DESIGN (2018)
Tumor Targeting Synergistic Drug Delivery by Self-Assembled Hybrid Nanovesicles to Overcome Drug Resistance
Meng-Qing Gong et al.
PHARMACEUTICAL RESEARCH (2017)
3-bromopyruvate and buthionine sulfoximine effectively kill anoikis-resistant hepatocellular carcinoma cells
Minjong Lee et al.
PLOS ONE (2017)
Co-delivery of multiple drug resistance inhibitors by polymer/inorganic hybrid nanoparticles to effectively reverse cancer drug resistance
Cong Wu et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2017)
Molecular biology of human epidermal receptors, signaling pathways and targeted therapy against cancers: new evidences and old challenges
Paulo Michel Pinheiro Ferreira et al.
BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Developing the WCRF International/University of Bristol Methodology for Identifying and Carrying Out Systematic Reviews of Mechanisms of Exposure-Cancer Associations
Sarah J. Lewis et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Inhibition of glutathione metabolism attenuates esophageal cancer progression
Liang Peng et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2017)
Clinically Evaluated Cancer Drugs Inhibiting Redox Signaling
D. Lynn Kirkpatrick et al.
ANTIOXIDANTS & REDOX SIGNALING (2017)
The effects of buthionine sulfoximine on the proliferation and apoptosis of biliary tract cancer cells induced by cisplatin and gemcitabine
Qiwei Li et al.
ONCOLOGY LETTERS (2016)
Epithelial cell adhesion molecule in human hepatocellular carcinoma cell lines: a target of chemoresistence
Yan Li et al.
BMC CANCER (2016)
Comprehensive comparison of molecular portraits between cell lines and tumors in breast cancer
Guanglong Jiang et al.
BMC GENOMICS (2016)
GSH-targeted nanosponges increase doxorubicin-induced toxicity in vitro and in vivo in cancer cells with high antioxidant defenses
Martina Daga et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
Nanomedicine of synergistic drug combinations for cancer therapy - Strategies and perspectives
Rui Xue Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2016)
A Multilaboratory Toxicological Assessment of a Panel of 10 Engineered Nanomaterials to Human Health-ENPRA Project-The Highlights, Limitations, and Current and Future Challenges
Ali Kermanizadeh et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS (2016)
A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma
Judith G. Villablanca et al.
PEDIATRIC BLOOD & CANCER (2016)
Sulindac sulfide selectively increases sensitivity of ABCC1 expressing tumor cells to doxorubicin and glutathione depletion
Jason D. Whitt et al.
JOURNAL OF BIOMEDICAL RESEARCH (2016)
Counteracting effects on free radicals and histological alterations induced by a fraction with casearins
Everton Jose Ferreira De Araujo et al.
ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS (2015)
2-deoxy-D-Glucose Synergizes with Doxorubicin or L-Buthionine Sulfoximine to Reduce Adhesion and Migration of Breast Cancer Cells
Ebtihal H Mustafa et al.
Asian Pacific Journal of Cancer Prevention (2015)
Preclinical Mouse Cancer Models: A Maze of Opportunities and Challenges
Chi-Ping Day et al.
CELL (2015)
Dual targeting of the thioredoxin and glutathione antioxidant systems in malignant B cells: A novel synergistic therapeutic approach
Michelle Kiebala et al.
EXPERIMENTAL HEMATOLOGY (2015)
Enhancement of Selectivity of an Organometallic Anticancer Agent by Redox Modulation
Isolda Romero-Canelon et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
A resource for cell line authentication, annotation and quality control
Mamie Yu et al.
NATURE (2015)
Autophagy Interplays with Apoptosis and Cell Cycle Regulation in the Growth Inhibiting Effect of Trisenox in HEP-2, a Laryngeal Squamous Cancer
Debora Lima Pereira et al.
PATHOLOGY & ONCOLOGY RESEARCH (2015)
Oxidative stress, cell cycle arrest and differentiation contribute toward the antiproliferative action of BSO and calcitriol on Caco-2 cells
Ana C. Liaudat et al.
ANTI-CANCER DRUGS (2014)
SYRCLE's risk of bias tool for animal studies
Carlijn R. Hooijmans et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
Enhancement of arsenic trioxide-induced apoptosis in HeLa cells by diethyldithiocarbamate or buthionine sulfoximine
Yong Han et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Meta-analysis of data from animal studies: A practical guide
H. M. Vesterinen et al.
JOURNAL OF NEUROSCIENCE METHODS (2014)
Fixing problems with cell lines
Jon R. Lorsch et al.
SCIENCE (2014)
The pro-oxidant buthionine sulfoximine (BSO) reduces tumor growth of implanted Lewis lung carcinoma in mice associated with increased protein carbonyl, tubulin abundance, and aminopeptidase activity
Isabel Rodriguez-Gomez et al.
TUMOR BIOLOGY (2014)
Modulation of oxidative stress as an anticancer strategy
Chiara Gorrini et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Evaluating cell lines as tumour models by comparison of genomic profiles
Silvia Domcke et al.
NATURE COMMUNICATIONS (2013)
Susceptibility of Human Head and Neck Cancer Cells to Combined Inhibition of Glutathione and Thioredoxin Metabolism
Arya Sobhakumari et al.
PLOS ONE (2012)
In vitro and in vivo anticancer properties of cucurbitacin isolated from Cayaponia racemosa
Gardenia C. G. Militao et al.
PHARMACEUTICAL BIOLOGY (2012)
Inhibition of glutathione synthesis eliminates the adaptive response of ascitic hepatoma 22 cells to nedaplatin that targets thioredoxin reductase
Yijun Wang et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2012)
Preclinical evaluation of azathioprine plus buthionine sulfoximine in the treatment of human hepatocarcinoma and colon carcinoma
Borja Hernandez-Breijo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Paclitaxel combined with inhibitors of glucose and hydroperoxide metabolism enhances breast cancer cell killing via H2O2-mediated oxidative stress
Tanja Hadzic et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Glutathione: Overview of its protective roles, measurement, and biosynthesis
Henry Jay Forman et al.
MOLECULAR ASPECTS OF MEDICINE (2009)
Glutathione and related enzymes: Biological roles and importance in pathological processes
Paula C. Huber et al.
QUIMICA NOVA (2008)
Lack of mitochondrial depolarization by oxidative stress is associated with resistance to buthionine sulfoximine in acute lymphoblastic leukemia cells
Hiroaki Goto et al.
LEUKEMIA RESEARCH (2007)
Buthionine sulfoximine increases the toxicity of nifurtimox and benznidazole to Trypanosoma cruzi
M Faundez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine
H Maeda et al.
CELL DEATH AND DIFFERENTIATION (2004)
Synergistic cytotoxicity of buthionine sulfoximine (BSO) and intensive melphalan (L-PAM) for neuroblastoma cell lines established at relapse after myeloablative therapy
CP Anderson et al.
BONE MARROW TRANSPLANTATION (2002)
Cellular glutathione content, in vitro chemoresponse, and the effect of BSO modulation in samples derived from patients with advanced ovarian cancer
GM Lewandowicz et al.
GYNECOLOGIC ONCOLOGY (2002)
Potentiation of cadmium-induced cytotoxicity by sulfur amino acid deprivation through activation of extracellular signal-regulated kinase1/2 (ERK1/2) in conjunction with p38 kinase or c-jun N-terminal kinase (JNK) - Complete inhibition of the potentiated toxicity by U0126 an ERK1/2 and p38 kinase inhibitor
MH Son et al.
BIOCHEMICAL PHARMACOLOGY (2001)
Enhanced hydroxychavicol-induced cytotoxic effects in glutathione-depleted HepG2 cells
CL Chen et al.
CANCER LETTERS (2000)
Inhibition of glutathione synthesis as a chemotherapeutic strategy for leishmaniasis
P Kapoor et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2000)
Share Paper
